Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ESP, EORTC, and EURACAN Expert Opinion: practical recommendations for the pathological diagnosis and clinical management of intermediate melanocytic tumors and rare related melanoma variants.
de la Fouchardiere A, Blokx W, van Kempen LC, Luzar B, Piperno-Neumann S, Puig S, Alos L, Calonje E, Massi D; ESP Dermatopathology Working Group; EORTC Melanoma Group; EURACAN. de la Fouchardiere A, et al. Among authors: van kempen lc. Virchows Arch. 2021 Jul;479(1):3-11. doi: 10.1007/s00428-020-03005-1. Epub 2021 Jan 12. Virchows Arch. 2021. PMID: 33432480
An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma.
Cook MG, Massi D, Szumera-Ciećkiewicz A, Van den Oord J, Blokx W, van Kempen LC, Balamurugan T, Bosisio F, Koljenović S, Portelli F, van Akkooi ACJ; EORTC Melanoma Group. Cook MG, et al. Among authors: van akkooi acj, van den oord j, van kempen lc. Eur J Cancer. 2019 Jun;114:1-7. doi: 10.1016/j.ejca.2019.03.010. Epub 2019 Apr 17. Eur J Cancer. 2019. PMID: 31005015
SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment.
Szumera-Ciećkiewicz A, Bosisio F, Teterycz P, Antoranz A, Delogu F, Koljenović S, van de Wiel BA, Blokx W, van Kempen LC, Rutkowski P, Christopher van Akkooi A, Cook M, Massi D; EORTC Melanoma Group. Szumera-Ciećkiewicz A, et al. Among authors: van de wiel ba, van kempen lc. Eur J Cancer. 2020 Sep;137:175-182. doi: 10.1016/j.ejca.2020.06.037. Epub 2020 Aug 8. Eur J Cancer. 2020. PMID: 32781392
Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression.
van Kempen LC, van den Hurk K, Lazar V, Michiels S, Winnepenninckx V, Stas M, Spatz A, van den Oord JJ. van Kempen LC, et al. Among authors: van den oord jj, van den hurk k. Virchows Arch. 2012 Oct;461(4):441-8. doi: 10.1007/s00428-012-1309-9. Epub 2012 Sep 6. Virchows Arch. 2012. PMID: 22956368
Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics.
Eijkelenboom A, Tops BBJ, van den Berg A, van den Brule AJC, Dinjens WNM, Dubbink HJ, Ter Elst A, Geurts-Giele WRR, Groenen PJTA, Groenendijk FH, Heideman DAM, Huibers MMH, Huijsmans CJJ, Jeuken JWM, van Kempen LC, Korpershoek E, Kroeze LI, de Leng WWJ, van Noesel CJM, Speel EM, Vogel MJ, van Wezel T, Nederlof PM, Schuuring E, Ligtenberg MJL. Eijkelenboom A, et al. Among authors: van kempen lc, van wezel t, van noesel cjm, van den berg a, van den brule ajc. Virchows Arch. 2019 Jun;474(6):673-680. doi: 10.1007/s00428-019-02555-3. Epub 2019 Mar 19. Virchows Arch. 2019. PMID: 30888490 Free PMC article.
Epidemiology of extracutaneous melanoma in the Netherlands.
Koomen ER, de Vries E, van Kempen LC, van Akkooi AC, Guchelaar HJ, Louwman MW, Nijsten T, Coebergh JW. Koomen ER, et al. Among authors: van kempen lc, van akkooi ac. Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1453-9. doi: 10.1158/1055-9965.EPI-09-1267. Epub 2010 May 25. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20501769
Angiosarcomatous transdifferentiation of metastatic melanoma.
Kilsdonk MJ, Romeijn TR, Kelder W, van Kempen LC, Diercks GF. Kilsdonk MJ, et al. Among authors: van kempen lc. J Cutan Pathol. 2020 Dec;47(12):1211-1214. doi: 10.1111/cup.13857. Epub 2020 Sep 28. J Cutan Pathol. 2020. PMID: 32865830 Free PMC article.
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.
Koopman B, Groen HJM, Ligtenberg MJL, Grünberg K, Monkhorst K, de Langen AJ, Boelens MC, Paats MS, von der Thüsen JH, Dinjens WNM, Solleveld N, van Wezel T, Gelderblom H, Hendriks LE, Speel EM, Theunissen TE, Kroeze LI, Mehra N, Piet B, van der Wekken AJ, Ter Elst A, Timens W, Willems SM, Meijers RWJ, de Leng WWJ, van Lindert ASR, Radonic T, Hashemi SMS, Heideman DAM, Schuuring E, van Kempen LC. Koopman B, et al. Among authors: van der wekken aj, van lindert asr, van kempen lc, van wezel t. Oncologist. 2021 Aug;26(8):e1347-e1358. doi: 10.1002/onco.13580. Epub 2020 Nov 10. Oncologist. 2021. PMID: 33111480 Free PMC article.
Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non-Small-Cell Lung Cancer With Rare or Complex Mutational Profiles.
Koopman B, van der Wekken AJ, Ter Elst A, Hiltermann TJN, Vilacha JF, Groves MR, van den Berg A, Hiddinga BI, Hijmering-Kappelle LBM, Stigt JA, Timens W, Groen HJM, Schuuring E, van Kempen LC. Koopman B, et al. Among authors: van der wekken aj, van kempen lc, van den berg a. JCO Precis Oncol. 2020 Nov;4:393-410. doi: 10.1200/PO.20.00008. JCO Precis Oncol. 2020. PMID: 35050740
114 results